🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Community Health Systems, Inc. CYH R2K

Healthcare · Medical Care Facilities · United States
https://www.chs.net
Company Profile ↓
$3.19
-14.02% 1Y
Mkt Cap$449.52M
P/E0.93
P/B-0.29
52W High$4.41
52W Low$2.44
Book Value$-10.73
EPS (TTM)$3.44

Company Overview

Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. The company offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. It also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, and direct-to-consumer virtual health visits. Community Health Systems, Inc. was founded in 1985 and is headquartered in Franklin, Tennessee.

Why Investors Should Care

Reasonable Valuation

Trades at a P/E of 0.9, below the sector median of 25.4.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $12.48B (-1.2% YoY); net profit $509.00M.
  • Trailing 12 Months Year-on-year growth — revenue -6.1%.
  • 5-Year Trend Long-term compounding — revenue CAGR -4.2%, profit CAGR 5.1%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-4.24%
1 Year:-6.10%

Compounded Profit Growth

5 Years:5.11%
1 Year:-

Stock Price Performance

1 Year:-14.02%
6 Months:-3.92%
3 Months:+4.25%
1 Month:+4.59%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 38% of range
$2.44 $4.41
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMABelow
  • RSI (14)46.54 · Neutral
Price Performance
1M+4.59%
3M+4.25%
6M-3.92%
1Y-14.02%
Valuation vs Sector

P/E of 0.93 is below the sector median of 25.41 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Generates positive free cash flow.

CONS

  • Revenue declined at -4.2% CAGR over 5 years.
  • Trading 27.7% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
0.93
Industry PE
25.41
Forward P/E
33.58
PEG Ratio
2.38
Book Value
$-10.73
Price to Book
-0.29
P/S
0.04
EV/EBITDA
7.91
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-4.24%
Profit 5Y
5.11%
Revenue (YoY)
-6.10%
Earnings (YoY)
-

Profitability & Returns

ROCE
13.53%
ROE
-36.51%
ROA
4.68%
Profit Margin
3.78%
Op Margin
6.44%
Gross Margin
41.60%
EPS (Latest Qtr)
$-0.43
EPS (TTM)
$3.44

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
1.19
Current Ratio
1.47
Debt
$10.76B
Total Assets
$13.18B
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
15.20%
Chg in Prom Hold
0.01%
FII / Inst Holding
78.78%
Chg in FII Hold
-0.00%

Financial Snapshot

Enterprise Value
$449.52M
Total Revenue (TTM)
$12.29B
EBITDA
$1.39B
Free Cash Flow
$337.88M
Operating Cash Flow
$126.00M
Shares Outstanding
140.92M
Gross Margin
41.60%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 CYH Community Health Systems, Inc. R2K 3.19 0.93 $449.52M 0.00% 13.53% -36.51% -4.24% 5.11%
2 LLY Eli Lilly and Company SPX 1,152.54 41.02 $1.03T 0.61% - 107.46% 7.20% 11.41%
3 JNJ Johnson & Johnson SPX 253.85 29.45 $611.07B 2.23% 14.88% 26.42% 2.43% 4.76%
4 ABBV AbbVie Inc. SPX 244.78 119.40 $432.48B 3.04% 10.47% -129.24% 1.75% -29.06%
5 UNH UnitedHealth Group Incorporated SPX 425.19 32.02 $386.13B 2.27% 9.74% 12.18% 10.40% 5.43%
6 MRK Merck & Co., Inc. SPX 120.78 34.02 $298.31B 2.86% - 18.94% 5.64% 10.01%
7 AZN AstraZeneca PLC NDX 164.50 24.81 $255.12B 1.77% 15.97% 23.48% 9.82% 45.96%
8 TMO Thermo Fisher Scientific Inc. SPX 534.07 29.33 $198.47B 0.40% 8.14% 13.52% 8.81% 12.95%
9 AMGN Amgen Inc. NDXSPX 355.25 24.69 $191.73B 2.84% 18.02% 101.32% 11.77% 5.58%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ---------4.49B4.14B3.67B3.06B3.69B3.56B3.45B3.45B3.38B3.30B3.25B3.29B3.02B2.52B3.13B3.01B3.01B3.12B3.11B2.93B3.02B3.11B3.12B3.09B3.14B3.14B3.09B3.16B3.13B3.09B2.96B
Operating Income -399.00M441.00M351.00M-294.00M-1.38B146.00M-71.00M113.00M90.00M-212.00M37.00M74.00M-189.00M111.00M184.00M-110.00M296.00M285.00M326.00M314.00M340.00M270.00M119.00M204.00M210.00M246.00M173.00M231.00M238.00M-205.00M284.00M512.00M243.00M281.00M
Net Income 100.00M79.00M111.00M52.00M-83.00M11.00M-1.43B-79.00M-220.00M-199.00M-137.00M-110.00M-2.01B-25.00M-110.00M-325.00M-328.00M-118.00M-167.00M-17.00M-373.00M18.00M70.00M112.00M-64.00M6.00M111.00M-1.00M-326.00M-42.00M-51.00M-38.00M-91.00M-41.00M-13.00M-391.00M-13.00M282.00M130.00M-58.00M
Diluted EPS 0.870.680.950.44-0.730.10-12.91-0.71-1.99-1.79-1.22-0.98-17.98-0.22-0.97-2.88-2.91-1.04-1.47-0.15-3.270.150.610.97-0.510.040.85-0.01-2.52-0.32-0.40-0.29-0.69-0.32-0.10-2.95-0.102.090.96-0.43

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue --------18.44B15.35B14.15B13.21B11.79B12.37B12.21B12.49B12.63B12.48B
Operating Income 971.88M1.06B1.12B1.13B1.23B917.00M1.34B1.34B-860.00M-1.88B208.00M650.00M1.13B1.40B821.00M957.00M542.00M1.49B
Net Income 218.30M243.15M279.98M201.95M266.00M141.00M92.00M158.00M-1.72B-2.46B-788.00M-675.00M511.00M230.00M46.00M-133.00M-516.00M509.00M
Diluted EPS 2.322.663.012.232.961.510.821.37-15.54-22.00-6.99-5.934.391.760.35-1.02-3.903.77

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --14.02B14.70B15.21B16.61B17.12B27.42B26.59B21.94B17.45B15.86B15.61B16.01B15.22B14.67B14.46B14.05B13.20B
Total Equity 1.74B1.67B1.95B2.19B2.40B2.73B3.07B4.00B4.02B1.61B-767.00M-1.53B-2.22B-1.62B-1.37B-1.37B-1.39B-1.91B-1.39B
Cash & Equivalents 133.57M220.66M344.54M299.17M130.00M388.00M373.00M509.00M184.00M238.00M563.00M196.00M216.00M1.68B507.00M118.00M38.00M37.00M260.00M
Long Term Debt ----8.85B9.54B9.45B16.92B17.05B15.24B13.91B13.39B13.38B12.09B12.11B11.61B11.47B11.43B10.38B
Total Liabilities --11.64B12.06B12.35B13.44B13.63B22.81B21.92B19.66B17.61B16.82B17.25B17.06B16.03B15.40B15.28B15.37B14.04B
Current Liabilities --1.46B1.64B1.91B2.14B2.46B3.59B3.07B2.89B2.36B2.39B2.28B2.81B2.36B2.19B2.14B2.35B2.21B

Cash Flows (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 1.06B1.08B1.19B1.26B1.28B1.09B1.61B921.00M1.14B773.00M274.00M385.00M2.18B-131.00M300.00M210.00M480.00M543.00M
Investing Cash Flow -665.47M-867.18M-1.04B-1.20B-1.38B-991.00M-4.35B-1.05B630.00M1.07B-245.00M-2.00M177.00M-524.00M-259.00M-26.00M-275.00M847.00M
Financing Cash Flow -304.03M-85.36M-189.79M-235.44M361.00M-113.00M2.87B-195.00M-1.71B-1.52B-396.00M-363.00M-895.00M-514.00M-430.00M-264.00M-206.00M-1.17B
Capital Expenditure -692.23M-576.89M-667.38M-776.71M-769.00M-614.00M-853.00M-953.00M-744.00M-564.00M-527.00M-438.00M-440.00M-469.00M-415.00M-467.00M-360.00M-335.00M
Free Cash Flow 364.35M499.54M521.35M485.19M511.00M475.00M762.00M-32.00M393.00M209.00M-253.00M-53.00M1.74B-600.00M-115.00M-257.00M120.00M208.00M
Share Buybacks 90.19M-113.96M85.79M-27.00M9.00M159.00M----------

Ratios (Annual)

Figures in %.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ------------------
Operating Margin % ---------4.7%-12.2%1.5%4.9%9.6%11.3%6.7%7.7%4.3%11.9%
Net Margin % ---------9.3%-16.0%-5.6%-5.1%4.3%1.9%0.4%-1.1%-4.1%4.1%
ROE % 13.1%12.5%12.8%8.4%9.7%4.6%2.3%3.9%-106.6%320.6%51.3%30.4%-31.4%-16.8%-3.4%9.6%27.0%-36.5%
ROCE % -8.5%8.6%8.5%8.5%6.3%5.6%5.7%-4.5%-12.4%1.5%4.9%8.5%10.9%6.6%7.8%4.6%13.5%

Shareholding Pattern

Insiders
15.20%
Institutions
78.78%
Public Float
92.90%

Top Institutional Holders

#Holder% HeldSharesValue
1 Castleknight Management LP 8.99% 12.67M $47.38M
2 Apollo Management Holdings, L.P. 8.15% 11.49M $42.97M
3 Blackrock Inc. 6.96% 9.80M $36.66M
4 Eversept Partners, LP 6.16% 8.68M $32.45M
5 Nomura Holdings Inc. 4.89% 6.89M $25.75M
6 Vanguard Capital Management LLC 3.81% 5.38M $20.10M
7 Whitebox Advisors, LLC 2.22% 3.13M $11.70M
8 Two Sigma Investments, LP 2.13% 3.00M $11.22M
9 Vanguard Portfolio Management LLC 2.12% 2.99M $11.20M
10 State Street Corporation 2.07% 2.92M $10.93M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CYH

Google News Mon, 22 Jun 2026

Community Health Systems (CYH) Stock Sees Split Analyst Revisions On CMS Rule Concerns - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxOTjVEQkdLOUNybWRYeXJsazZfVkZzVnVDREw3LTBoblJqQW1hR0Ywa282M0pOY1VkbFpSYnZ1OFVXTUR2SHJGZy1UZGNNNGs5ZnBHR2haNUFnVUFNSXg4RGdwVlI4aW5rUUNZc0NQX0dzSVZWSDB0NlR0QV9SRUNQTHN1UXFjemlYNldHVX…

Google News Wed, 08 Jul 2026

Community Health Systems plans Q2 call, results July 22 - Stock Titan

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxOZG9YY2d0bjl2dDVseXV6bTVMclVSN1JOQl9LNy11c2o1SGo5UnQ0VzQwb2lRdzMtNExqS19YVDdZYVhqZnVkT1JMYV92RXlYRWxGR1ZKX01Yc0dnU2ppVGxsNTJiMUtfY1NNaFhBS2YxVG9PNmcxRXlsRlJoRWtNSGpTTWNHemxiTjJMYl…

Google News hu, 09 Jul 2026

Community Health Systems(CYH) Stock Options Chain | Quotes & News - Moomoo

<a href="https://news.google.com/rss/articles/CBMiqAJBVV95cUxQR2stczU3aFQ3QmpRZUhXWjN0bDFURVBvYmY4bktCd0JfeWpWVm5TN2N3WF94Y2ZnV3M0c1VEeGFQbjlvOV96cDM0U1N4eTVxZ2lDTzhRVnU5REVSLTJfTHB4M1hmaXpOaWVHUk9QblNEUjdubk02b051VzZ1aGx2WWp3ODFROXBNOW8waC…

Google News Sun, 12 Jul 2026

CYH,THC Dividends - Finviz

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9kYnlhcmxQdzRldWQzbWhHRGN1ekhoTzRZeUFWbGtoenRzZ2x0WjVfbTVNTk1hcE5rSENJc2YyN2xPZURSeWg0WnRQeW9sVVlibWdNOEFDRVdlLWVXbkpkdA?oc=5" target="_blank">CYH,THC Dividends</a>&nbsp;&nbsp;<fon…

Google News Fri, 26 Jun 2026

CYH Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE1jdW02YmVfeTcxWUZlbnRLMUQ4MlVlN2swTldoaDBvY1JFeGQxdnRpSnBoWjdCWWM4Y3VxSjhRbnJwS3R5cVUzemZHTWswM01Oby1WWEotNWE0djRQazBETlh2R0oyS0ZUenpETGZTQjE5YnprYlE?oc=5" target="_blank">CYH Fore…

Google News ue, 14 Jul 2026

Truist Raises Price Target on Community Health Systems to $3.75 From $3, Keeps Hold Rating - marketscreener.com

<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxOUnBCeWhfUU4tNVJHc01XQW1OY0taaUZ5dzNxWDlZSEF5dDRTTmZqb1pKeFVzUzVobkZ6MzlBeXBxTE5OVmNIdHhVTmplb2oyUFFlclVyQmEwNDZhLU9tSUNnOHFmY2VkSTR1Y2dVNGl1XzdvVHVBZVM5V2tHX01OQzZhSlc1Sm1LaEpGQk…

CYH — Frequently Asked Questions

What is the current share price of Community Health Systems, Inc. (CYH)?

As of 2026-07-14 21:23 PDT, Community Health Systems, Inc. (CYH) trades at $3.19 on NYSE. Its 52-week range is $2.44 to $4.41.

What is the market capitalisation of CYH?

Community Health Systems, Inc. (CYH) has a market capitalisation of $449.52M on NYSE.

What is the P/E ratio of CYH?

CYH trades at a trailing price-to-earnings (P/E) ratio of 0.93. The industry average P/E is 25.41. Its price-to-book (P/B) ratio is -0.29.

What is the return on equity (ROE) of CYH?

CYH has a return on equity (ROE) of -36.51%. Its return on capital employed (ROCE) is 13.53%.

Is CYH a good stock to buy?

This page provides a data-driven analysis of Community Health Systems, Inc. (CYH), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space